Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple ultrasound replace X-Rays for pneumonia diagnosis?

NCT ID NCT04210102

Diagnosis Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares lung ultrasound (LUS) with chest X-ray for diagnosing community-acquired pneumonia in emergency room patients. Researchers will enroll 47 adults with suspected pneumonia to see if LUS is as accurate as X-ray. If LUS proves reliable, it could offer a faster, radiation-free way to diagnose pneumonia and reduce unnecessary antibiotic use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lung ultrasound (diagnostic test)
What this could lead to
If successful, this could show that lung ultrasound is as good as or better than chest X-ray for diagnosing pneumonia, potentially reducing unnecessary antibiotic use and radiation exposure.
What could go wrong
This is a small, single-center study with only 47 participants, so results may not apply to all patients. Ultrasound accuracy can also depend heavily on the operator's skill.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

47 people

The number who actually took part.

Started

Feb 2020

Expected to finish

Jan 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (18+) * Suspected CAP by attending emergency physician * And new onset of systemic infection (at least one among sweat, chills, aches and pain, temperature ≥38°C or \<36°C) * And symptoms of an acute lower respiratory tract infection (at least one among cough, sputum production, dyspnea, chest pain, altered breathing sounds at auscultation * No previous imaging for the current medical problem * Inform consent (signed) * Affiliation to insurance (France, Monaco) Exclusion Criteria: * Age below 18-year of age * Patients in palliative care * Pregnant women * anticipated barriers to completing follow-up data collection, * patients classified three or higher according to the CRB65 score, * patients requiring intensive care for any purpose because of specific management of critically ill * refusal to participate to the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Community-acquired pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Community-Acquired Pneumonia pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Community-acquired pneumonia

Contacts and locations

Locations

  • CHPG

    Monaco, Monaco

More trials for these conditions

Other studies related to the condition(s) this trial covers.